Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Gsk Plc (GSK.LN)

Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Nasdaq Times Square by Lucky Photographer via iStock
Nasdaq Futures Climb on Upbeat Alphabet Results, U.S. GDP Data and More Big Tech Earnings on Tap Barchart - Wed Oct 30, 4:40AM CDT

December Nasdaq 100 E-Mini futures (NQZ24) are trending up +0.28% this morning as strong quarterly results from Alphabet boosted sentiment, while investors also awaited a fresh batch of U.S. economic data...

PYPL : 87.13 (+0.40%)
KLAC : 629.37 (+1.16%)
GOOGL : 191.41 (+1.54%)
META : 585.25 (-1.73%)
AVGO : 220.79 (+1.13%)
RDDT : 170.71 (+4.27%)
F : 9.88 (+1.44%)
NQZ24 : 20,947.98s (-0.78%)
ABBV : 175.58 (+2.37%)
SNAP : 11.40 (+0.88%)
DASH : 171.00 (+2.00%)
GSK.LN : 1,308.500 (-1.02%)
Wall Street - New York Stock Exchange NYSE in Manhattan by 4kclips via Shutterstock
Stocks Muted Before the Open With U.S. Inflation Data in Focus Barchart - Thu Oct 10, 4:42AM CDT

December S&P 500 E-Mini futures (ESZ24) are down -0.15%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -0.23% this morning as investors refrained from making any big bets ahead of a key U.S....

PYPL : 87.13 (+0.40%)
GOOGL : 191.41 (+1.54%)
CVS : 44.36 (+1.32%)
TXG : 14.04 (+3.16%)
JPM : 237.60 (+1.99%)
NQZ24 : 20,947.98s (-0.78%)
NKE : 76.94 (-0.21%)
GSK.LN : 1,308.500 (-1.02%)
PFE : 26.36 (+2.29%)
NCLH : 26.91 (+5.90%)
WFC : 70.34 (+2.16%)
ALTM : 4.85 (-0.61%)
Wall Street - shutterstock_1321462400
Stocks Set to Open Higher as Rate Cut Bets Firm, U.S. Jobs Data in Focus Barchart - Mon Jun 3, 4:33AM CDT

June S&P 500 E-Mini futures (ESM24) are up +0.25%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.37% this morning as speculation over interest rate cuts by major central banks heightened appetite...

ESM24 : 5,471.89s (-0.09%)
NQM24 : 19,747.29s (-0.08%)
CZR : 32.82 (-0.76%)
ZS : 187.38 (+2.28%)
GPS : 24.55 (+4.38%)
MDB : 245.63 (+0.26%)
CRWD : 362.29 (+3.21%)
GTLB : 59.83 (+7.49%)
HPE : 21.61 (+4.09%)
BBWI : 39.27 (+1.79%)
LULU : 379.42 (+1.57%)
DLTR : 72.94 (+5.62%)
Moderna Investors Just Got Some Bullish News Motley Fool - Mon Jun 3, 3:50AM CDT

This news could be worth billions...

GSK.LN : 1,308.500 (-1.02%)
PFE : 26.36 (+2.29%)
MRNA : 39.39 (-0.43%)
Is This a Setback for Moderna? Motley Fool - Tue May 14, 5:35AM CDT

Moderna's shares slipped after the company announced the delay.

PFE : 26.36 (+2.29%)
GSK.LN : 1,308.500 (-1.02%)
MRNA : 39.39 (-0.43%)
Drug Patents
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition Associated Press - Tue Apr 30, 4:36PM CDT

The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic

AZN.LN : 10,222.000 (-0.21%)
AZN : 65.35 (+1.41%)
GSK.LN : 1,308.500 (-1.02%)
GSK : 33.60 (+0.51%)
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. Motley Fool - Tue Apr 9, 5:35AM CDT

These companies are close to launching new products that could supercharge revenue.

LLY : 767.76 (+1.35%)
PFE : 26.36 (+2.29%)
GSK.LN : 1,308.500 (-1.02%)
MRNA : 39.39 (-0.43%)
VRTX : 397.27 (+0.16%)
RSV Drug
Babies should get recently approved drug for RSV, CDC says Associated Press - Thu Aug 3, 2023

U.S. health officials are recommending that babies get a recently approved drug to protect them against a respiratory virus

PFE : 26.36 (+2.29%)
GSK.LN : 1,308.500 (-1.02%)
GSK : 33.60 (+0.51%)
AZN.LN : 10,222.000 (-0.21%)
AZN : 65.35 (+1.41%)
Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health Newswire.ca - Wed Jun 28, 2023

/CNW/ - GSK plc (LSE: GSK) (NYSE: GSK) and BELLUS Health Inc. (TSX: BLU) NASDAQ: BLU) today announced GSK has completed the acquisition of BELLUS, a...

BLU : 14.74 (unch)
GSK.LN : 1,308.500 (-1.02%)
GSK : 33.60 (+0.51%)
BLU.TO : 19.48 (-0.10%)
Author
ImmunoGen Nearly Triples on Ovarian Cancer Drug Phase 3 Results MarketBeat - Mon May 8, 2023

Commercial-state biotechnology company ImmunoGen Inc. (NASDAQ: IMGN) shares more than doubled on phase 3 clinical trial results. Its ovarian cancer drug

SGEN : 228.74 (-0.07%)
AZN : 65.35 (+1.41%)
IMGN : 31.23 (unch)
GSK : 33.60 (+0.51%)
GSK.LN : 1,308.500 (-1.02%)
PFE : 26.36 (+2.29%)

Barchart Exclusives

Is It Time to Sell This Second-Fiddle AI Stock Before 2025? Barchart - 48 minutes ago
Bank of America has cut its rating on AMD while lowering its price target. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot